20-hydroxy-5,8,11,14-eicosatetraenoic acid has been researched along with wortmannin in 1 studies
Studies (20-hydroxy-5,8,11,14-eicosatetraenoic acid) | Trials (20-hydroxy-5,8,11,14-eicosatetraenoic acid) | Recent Studies (post-2010) (20-hydroxy-5,8,11,14-eicosatetraenoic acid) | Studies (wortmannin) | Trials (wortmannin) | Recent Studies (post-2010) (wortmannin) |
---|---|---|---|---|---|
640 | 13 | 233 | 4,066 | 2 | 726 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bodiga, S; Buonaccorsi, JN; Dhanasekaran, A; Dunn, L; Falck, JR; Gao, Y; Gruenloh, S; Jacobs, ER; Medhora, M | 1 |
1 other study(ies) available for 20-hydroxy-5,8,11,14-eicosatetraenoic acid and wortmannin
Article | Year |
---|---|
20-HETE increases survival and decreases apoptosis in pulmonary arteries and pulmonary artery endothelial cells.
Topics: Androstadienes; Animals; Apoptosis; Caspase 3; Cattle; Cell Hypoxia; Cell Survival; Cells, Cultured; Endothelial Cells; Enzyme Activation; Hydroxyeicosatetraenoic Acids; Lipopolysaccharides; Mice; NADPH Oxidases; Phosphatidylinositol 3-Kinases; Phosphoinositide-3 Kinase Inhibitors; Protein Kinase Inhibitors; Proto-Oncogene Proteins c-akt; Pulmonary Artery; Reactive Oxygen Species; Wortmannin | 2009 |